I’m excited to invite you to the 9th Annual Houston Heart Failure Summit! Join us Saturday, 2/3/24 at @MethodistHosp or online. We are thrilled to have @DhariniRamu and @kamos16 as guest speakers reviewing the role of genetics in heart failure evaluation.
Thank you @mcolvin89 for joining us at @MethodistHosp and highlighting the importance of equity in access to advanced heart failure therapies! Look for the recording on the @DeBakeyCVedu YouTube channel to hear her insights into this critical issue.
Fantastic @HMethodistCV Grand Rounds by @RyanTedfordMD on RV assessment. Watch: https://t.co/Pcx3gBFeIo
Join @DeBakeyCVedu tomorrow for the George P. Noon Heart Failure Symposium to learn more from him and other leaders in the field of #LVAD!
Register: https://t.co/JxrTm2ytGU
Fantastic @HMethodistCV Grand Rounds by @RyanTedfordMD on RV reserve. Watch here: https://t.co/Pcx3gBFeIo.
Join @DeBakeyCVedu tomorrow at the George P. Noon Heart Failure Symposium to learn more from him and other leaders in the field of #LVAD.
Register https://t.co/JxrTm2ytGU
1/ Our RCT of med student guided tobacco cessation counseling of hospitalized patients in India
#MSCHAT trial is published in @JournalGIM
This implementation strategy
🌟⬆️ patient quit rates
🌟Improved student knowledge and confidence
Link ➡️https://t.co/ybD3bv0a2T
🧵
#HHFS2023@AlpeshShahMD
Let's talk next about HOW we do PCI!
💥PROTECT-II: Impella-assisted better than IABP-assisted PCI.
But why?
📍Reduced complications
📍Enables optimal lesion selection
📍Renal protection
Join us THIS SATURDAY for an in depth review of the impact of co-morbid conditions on heart failure outcomes! Don’t miss the opportunity to interact with leaders in the field including @MarkDrazner and @robmentz! @HMinternalmed@HMHCardioFellow@HFSA
Incredibly blessed and proud to have @WilliamZoghbi as my chief and mentor. Truly an inspirational leader who sets the bar high & supports your efforts to surpass it. Congratulations on a well-deserved recognition! @HMHCardioFellow@MethodistHosp
Humbled & honored to be recognized by @ASE360 — an amazing organization spearheading education and innovation at its core, along with its 17k+ members!
We are excited to announce our first keynote speaker for #HHFS2023: @MarkDrazner! He will kick off the first session by discussing the evaluation of new-onset #heartfailure! Be sure to join on Feb. 4!
REGISTER NOW: https://t.co/064X5kQe3W
#HFSA@utswheart@CindyMMartinMD
GLP-1R agonists & SGLT2 inhibitors are recommended first-line therapies for type 2 diabetes in patients with increased CV risk. Glucocentric Drugs in CV Disease Protection & Heart Failure @drtalhakhawaja@gcfmd@virani_md@JavedButler1#DeBakeyCVJournal
https://t.co/6hGGDTnVl4
Calling all #Cardiology 1st year fellows: SAVE THE DATE: #CVBootCamp2022 Aug 5-7! Don't miss the opportunity to get hand-ons training in cardiac imaging, heart failure, and more!
APPLY NOW at https://t.co/uE5sGD4hsh! Apps due July 1!
#CardioEd#CardioTwitter#EPeeps#WhyCMR